Category
Cancer
Sub Category
Breast
Study Name
S1207: Phase III Randomized, Placebo-Controlled Clinical Trial Evaluating the Use of Adjuvant Endocrine Therapy +/- One Year of Everolimus in Patients with High-Risk, Hormone Receptor-Postive and HER2/neu Negative Breast Cancer
Principal Investigator
Gordan Srkalovic MD, PhD
Study Information
Contact for Questions
Sparrow Cancer Center 800-968-5570

Site view: at a glance